Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Shining a New Light on The Immune System

By Drug Discovery Trends Editor | May 22, 2015

Source: ShutterstockScientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukemia and lymphoma from a small blood sample.

In a study published by journal PLOS ONE researchers used a light scattering technique called Wavelength Modulated Raman Spectroscopy (WMRS) to identify important types of white blood cells, including T lymphocytes, Natural Killer cells, and dendritic cells.

The immune system comprises a range of cell types that react to infections and other challenges, resulting in a powerful immune response with the aim of eradicating the infective agent or problem. Traditional methods of identifying and isolating these cells from blood usually involves labeling them with fluorescent or magnetically labeled antibodies.

This new method demonstrates the ability to identify immune cells with absolutely no labeling at all, thus permitting rapid identification and further analysis to take place with no potential alteration to the cells.

Raman scattering refers to light scattering from molecules in a sample where the light energy can be shifted up or down and recorded then as a ‘molecular fingerprint’ that can be used for identification.

Normally this process is very weak and further hampered by other background light (e.g. fluorescence).

The team at Physics and Astronomy at St Andrews have developed WMRS which subtly changes (modulates) the incident laser light that in turn results in a modulation of  the Raman signal, allowing it to be extracted from any (stationary) interfering signal. This means more accurate diagnosis of the sample.

The work was led by and Dr Simon Powis of the School of Medicine, and Prof Kishan Dholakia of the School of Physics and Astronomy, and continues the close collaboration of medical scientists and physicists in the area of biophotonics pioneered by the University in recent years.

Dr Powis, Reader in Immunology, said, “Under a normal light microscope these immune cells essentially all look identical. With this new method we can identify key cell types without any labeling.

“Our next goal is to make a full catalogue of all the normal cell types of the immune system that can be detected in the bloodstream. Once we have this completed, we can then collaborate with our clinical colleagues to start identifying when these immune cells are altered, in conditions such as leukemia and lymphoma, potentially providing a rapid detection system from just a small blood sample.”

Source: University of St. Andrews


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Columbia-CZ team develops 10.3M parameter model that outperforms 100M parameter rivals on cell type classification
Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE